AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Create a link to this page

Copy and paste this link tag into your Web page or blog:

<a href="http://www.accessmylibrary.com/article-1G1-131360011/fda-shift-painkillers-leaves.html" title="Facts and information about FDA's shift on painkillers leaves patients confused.">FDA's shift on painkillers leaves patients confused.</a>

Close Set up an RSS feed that alerts you when new articles from The Philadelphia Inquirer (Philadelphia, PA) are available.

Frequently asked questions about RSS feeds

FDA's shift on painkillers leaves patients confused.

The Philadelphia Inquirer (Philadelphia, PA)

| April 12, 2005 | COPYRIGHT 2007 The Philadelphia Inquirer. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: Marie McCullough

PHILADELPHIA _ Federal regulators let the arthritis drug Vioxx stay on the market for more than four years despite clinical trials linking it to heart attacks and strokes.

Last week, they asked the makers of Advil, Aleve, Mobic and other popular painkillers to add stern warnings about cardiovascular side effects to their labels _ despite a lack of strong data showing a risk.

"The FDA has sort of swung from saying there's no problem to saying everything is a problem," said Garrett FitzGerald, a University of Pennsylvania cardiologist and pharmacologist.

Some health-care providers and patients say they are confused, not comforted, by the U.S. Food and Drug Administration's sudden regulatory conservatism. And some experts say it renews questions about…

View articles courtesy of your local library

Related articles from newspapers, magazines, journals, and more


Drug Update: NSAIDs for Rheumatoid Arthritis.: Magazine article from: OB GYN News Zoler, Mitchel L. Imperio, Winnie Anne June 1, 2000 700+ words
...effective at relieving pain and inflammation than the older NSAIDs, and they share the older drugs' renal side effects...meloxicam (Mobic), is soon to be approved by the FDA. The older NSAIDs are generally similar; price is often the factor...


NSAIDs for Rheumatoid Arthritis.(Brief Article): Magazine article from: Family Practice News Zoler, Mitchel L. Imperio, Winnie Anne May 1, 2000 700+ words
...effective at relieving pain and inflammation than the older NSAIDs, and they share the older drugs renal side effects...meloxicam (Mobic), is soon to be approved by the FDA. The older NSAIDs are generally similar; price is often the factor...


Unhealthy wait for Merck: Safety fears: Outcome of study and FDA approval weigh...: News wire article from: The America's Intelligence Wire September 14, 2004 700+ words
...Arcoxia application has not gone before an FDA advisory panel, whose musings often give investors an idea on how the FDA will rule. Also, key data on the drug...which is blocked by COX-2 inhibitors and older NSAIDs, also helps make platel


Latest on Arthritis Painkillers: Glucosamine, Celebrex, and Vioxx.: Newspaper article from: HealthFacts Napoli, Maryann March 1, 2001 700+ words
...to be more effective than the older NSAIDs. The FDA panel's rulings centered on...gastrointestinal risk posed by the older NSAIDs. Pharmacia, the manufacturer...ibuprofen and diclofenac. The FDA panel concluded that the company...


Merck: more heartache.(Vioxx lawsuit)(drug giant Merck over its painkiller...: Magazine article from: Chemistry and Industry Dorey, Emma October 2, 2006 700+ words
...Federal Drug Administration (FDA), in an accompanying editorial...which is under review by the FDA. Merck has compared Arcoxia to an older NSAIDS, diclofenac, suggesting it...does so too. Graham claims the FDA's industry-friendly policies...


Cox-2 inhibitors under scrutiny.(Knight Ridder Newspapers): Newspaper article from: Knight Ridder/Tribune News Service McCullough, Marie December 18, 2004 700+ words
...market in September, and the FDA to add a "black box" warning...people's recognition of the older NSAIDS," Virtua's Grimmett said...Voltaren and Naproxen. The FDA, which has recently faced a...will face tough scrutiny at an FDA advisory committee meeting in...


Cox-2 inhibitors under scrutiny.: Newspaper article from: Philadelphia Inquirer (Philadelphia, PA) December 17, 2004 700+ words
...market in September, and the FDA to add a "black box" warning...people's recognition of the older NSAIDS," Virtua's Grimmett said...Voltaren and Naproxen. The FDA, which has recently faced a...will face tough scrutiny at an FDA advisory committee meeting in...


Risk linked to some painkillers creates dilemma.: News wire article from: Houston Chronicle (Houston, TX) April 17, 2005 700+ words
...cyclooxygenase-1, alone. (Older NSAIDS naproxen and ibuprofen...a similar threat, and FDA officials reasoned that...potential problems with older NSAIDS as well. That stance...Medicine, thinks the FDA's call for warning labels...


RxNews: Are New Painkillers Really Safe?: Newspaper article from: HealthFacts February 1, 1999 700+ words
...naproxen and all of the older NSAIDs also suppress prostacyclin...was approved by the FDA at the end of 1998...gut problems than older NSAIDs. The British Medicines...studies. But the FDA lacks the necessary...50 per pill) than older NSAIDs, many of which are...


... In with the new? Can we really trust new drugs to be safe and effective, or...: Magazine article from: Choice (Chippendale, Australia) September 1, 2005 700+ words
...Food and Drug Administration (FDA) was also aware of VIOXX...unapproved uses. However, the FDA was extremely slow to take further...handling of the VIOXX case. The FDA's Australian equivalent...better for the stomach than the older NSAIDs. An article in the British...

For more facts and information, see all results

The AccessMyLibrary advertising network includes: